The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis-Reference-Cited by-同舟云学术

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Published:2014-07-16 Issue:1 Volume:211 Page:80-90
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Mair-Jenkins John,Saavedra-Campos Maria,Baillie J. Kenneth,Cleary Paul,Khaw Fu-Meng,Lim Wei Shen,Makki Sophia,Rooney Kevin D.,Nguyen-Van-Tam Jonathan S.,Beck Charles R.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/211/1/80/13805440/jiu396.pdf

Reference50 articles.

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)—update (26 May 2014). http://www.who.int/csr/don/2014_05_23_mers/en/ Accessed 26 May 2014.

2. World Health Organization. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do. http://www.who.int/csr/disease/coronavirus_infections/InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13u.pdf Accessed 5 July 2014.

3. Public Health England, ISARIC. Treatment of MERS-CoV: decision support tool v.1.0. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139281416 Accessed 18 October 2013.

4. The WHO MERS-CoV Research Group. State of knowledge and data gaps of middle east respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr Outbreaks 2013. pii: ecurrents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8.

5. Hyperimmune IV Immunoglobulin Treatment

Cited by 811 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review;Life;2024-02-01

2. Middle East Respiratory Syndrome (MERS);Rising Contagious Diseases;2024-01-05

3. Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein;Antibodies;2024-01-05

4. COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2;Molecular Medical Microbiology;2024

5. Long-term antibody titers variation in unvaccinated patients receiving convalescent plasma or placebo for severe SARS-CoV-2 pulmonary infection.;Transfusion and Apheresis Science;2023-12